ChartRow logo
Sign in
ALNY
Alnylam Pharmaceuticals Inc.Stock · Health Care · Nasdaq-100 0.2%
$227.00+$3.05 (+1.36%)as of market close, Aug 13, 2026
☾ After hours:$227.12+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

How Alnylam Pharmaceuticals makes money

Period

How does Alnylam Pharmaceuticals make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Alnylam Pharmaceuticals Inc. · FY2025 · year ended 2025-12-31
Revenue$3.7BGross profit$3.0B · 82%Cost of revenue$677M · 18%Operating income$502M · 14%Operating expenses$2.5B · 68%R&D$1.3B · 36%SG&A$1.2B · 33%Pre-tax income$323M · 9%Other expense$178M · 5%Net income$314M · 8%Income tax$0 · 0%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.